MYC and neoplasm: Immunohistochemical staining of sections from tumor xenograft models demonstrated reduced protein levels of PRMT1 and c-MYC in tumor xenografts derived from TRIM25-knockdown GBM#021 cells relative to controls (Fig. 6I).